Actuate Therapeutics Inc (ACTU)
EBITDA Growth
17.46%
Quarterly · Period ending:
ACTU EBITDA Growth
Year-over-year change vs the same period a year earlier
Latest reported17.46%period ending
Latest reported17.46%period ending
ACTU Quarterly EBITDA YoY % (-29395.72% → 17.46%)
Year-over-year change
High-resolution chart · PNG
ACTU ebitda growth history
Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | EBITDA Growth |
|---|---|
| 17.4579% | |
| 10.9518% | |
| -3,950.5617% | |
| 9.4691% | |
| 9.4836% | |
| 23.8696% | |
| 1,360.0124% | |
| -4,278.6093% | |
| -10,173.0777% | |
| -29,395.7245% |